Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | HRAS |
| Variant | G12K |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | HRAS G12K does not lie within any known functional domains of the Hras protein (UniProt.org). G12K is transforming in cultured cells (PMID: 6092966), and can be predicted to lead to a loss of Hras protein function and activation of downstream signaling based on the effects of other HRAS G12 mutations. |
| Associated Drug Resistance | |
| Category Variants Paths |
HRAS mutant HRAS act mut HRAS G12K HRAS mutant HRAS G12X HRAS G12K |
| Transcript | NM_005343.4 |
| gDNA | chr11:g.534287_534289delGGCinsAAG |
| cDNA | c.34_36delGGCinsAAG |
| Protein | p.G12K |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_176795 | chr11:g.534287_534289delGCCinsCTT | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_176795.4 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_005343.3 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_001130442 | chr11:g.534287_534289delGCCinsCTT | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_005343 | chr11:g.534287_534289delGCCinsCTT | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_005343.4 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_001130442.3 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_001130442.2 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| NM_176795.5 | chr11:g.534287_534289delGGCinsAAG | c.34_36delGGCinsAAG | p.G12K | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| HRAS G12K | loss of function - predicted | MEK inhibitor (Pan) MEK1 Inhibitor MEK2 Inhibitor PI3K Inhibitor (Pan) PIK3CA inhibitor PIK3CB inhibitor PIK3CD inhibitor PIK3CG inhibitor RAS Inhibitor (Pan) |